Approval · Notice of Compliance 24653 · 2020
ZITHROMAX: Notice of Compliance 24653
Issued November 19, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 24653
- Date
- November 19, 2020
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To revise the design elements for the blister foil and carton labels for the 250 mg six-tablet presentation (single treatment blister package)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZITHROMAX | Not yet assigned | — |
Medicinal ingredients
- AZITHROMYCIN DIHYDRATE 250 MG per TAB